Brief: Cytodyn Signs Agreements With Vyera Pharmaceuticals To Commercialize Leronlimab In The U.S.

Cytodyn

17/12/2019 21:41

Dec 17 (Reuters) - Cytodyn Inc  CYDY.PK :
    * CYTODYN SIGNS DEFINITIVE AGREEMENTS WITH VYERA
PHARMACEUTICALS
TO COMMERCIALIZE LERONLIMAB IN THE U.S. FOR THE TREATMENT OF HIV
    * CYTODYN INC - VYERA WILL PAY UPFRONT AND REGULATORY AND
SALES-BASED MILESTONE PAYMENTS OF UP TO $87.5 MILLION
    * CYTODYN INC - VYERA WILL ALSO MAKE AN INVESTMENT IN
CYTODYN OF
$4 MILLION IN FORM OF REGISTERED CYTODYN COMMON STOCK
    * CYTODYN INC - VYERA WILL PAY A ROYALTY OF 50 PERCENT ON
NET
SALES OF LERONLIMAB
    * CYTODYN INC - CYTODYN WILL MAINTAIN RESPONSIBILITY FOR
DEVELOPMENT AND FDA APPROVAL OF LERONLIMAB FOR ALL HIV-RELATED
AND OTHER INDICATIONS

Source text for Eikon:  ID:nGNX6gqh8r 
Further company coverage:  CYDY.PK 

 ((Reuters.Briefs@thomsonreuters.com;))